Success Metrics

Clinical Success Rate
100.0%

Based on 14 completed trials

Completion Rate
100%(14/14)
Active Trials
0(0%)
Results Posted
36%(5 trials)

Phase Distribution

Ph phase_4
2
13%
Ph phase_2
1
7%
Ph phase_3
6
40%
Ph phase_1
6
40%

Phase Distribution

6

Early Stage

1

Mid Stage

8

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
6(40.0%)
Phase 2Efficacy & side effects
1(6.7%)
Phase 3Large-scale testing
6(40.0%)
Phase 4Post-market surveillance
2(13.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

14 of 14 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Completed(14)
Other(1)

Detailed Status

Completed14
unknown1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (40.0%)
Phase 21 (6.7%)
Phase 36 (40.0%)
Phase 42 (13.3%)

Trials by Status

completed1493%
unknown17%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT03169582Phase 4

Avanafil Versus Sildenafil in Spinal Cord Injury Erectile Dysfunction

Unknown
NCT02503306Phase 3

Efficacy and Tolerability Study of Avanafil in Russia

Completed
NCT01768676Phase 4

Study Evaluating the Effects of Avanafil on Semen Parameters

Completed
NCT02477436Phase 2

Efficacy and Safety of Avanafil in the Patients With Erectile Dysfunction

Completed
NCT00895011Phase 3

Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy

Completed
NCT00853606Phase 3

Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction

Completed
NCT00809471Phase 3

Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D)

Completed
NCT00790751Phase 3

Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED

Completed
NCT00769041Phase 1

A Thorough EKG Safety Study of TA-1790 (Avanafil)

Completed
NCT01054261Phase 1

To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function.

Completed
NCT01095601Phase 1

Assess the Effect of Food on Avanafil Pharmacokinetic (PK), to Compare 2 Oral Formulations of Avanafil,and Investigate Dose Proportionality in Healthy Male Subjects

Completed
NCT01054430Phase 1

To Assess the Safety of Avanafil in Healthy and Hepatically Impaired Male Subjects.

Completed
NCT01054859Phase 1

A Phase I Crossover Study of the Hemodynamic Interactions of Avanafil & Alcohol in Healthy Male Subjects.

Completed
NCT00903981Phase 3

Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Avanafil

Completed
NCT00770042Phase 1

To Evaluate The Effect Of Ketoconazole, Ritonavir and Erythromycin on the Safety and Pharmacokinetics of Avanafil

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15